Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of 3,5-di-tert-butyl copper salicylate to preparing drug for treating high-metastatic breast cancer

A technology of copper di-tert-butyl salicylate and high transfer, applied in the field of medicine, can solve problems such as the specific application of undisclosed chelate compounds, and achieve the effects of ensuring industrialized production, wide sources and high purity

Active Publication Date: 2016-03-23
JIANGHAN UNIVERSITY
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

It has been reported in the prior art that certain chelates of the trace element Cu include copper 3,5-diisopropyl salicylate Cu 2 (3,5-dips) 2 It has an inhibitory effect on the promotion and formation of tumors, but the specific application of the chelate has not been disclosed, so further research is required for clinical application

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of 3,5-di-tert-butyl copper salicylate to preparing drug for treating high-metastatic breast cancer
  • Application of 3,5-di-tert-butyl copper salicylate to preparing drug for treating high-metastatic breast cancer
  • Application of 3,5-di-tert-butyl copper salicylate to preparing drug for treating high-metastatic breast cancer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0020] The present invention will be further described in detail below in conjunction with the accompanying drawings and specific embodiments.

[0021] Effect of copper 3,5-di-tert-butylsalicylate on the metastatic ability of MDA-MB-231 and BT-20 cells

[0022] 1. Experimental materials

[0023] 1.1 Cell lines

[0024] Human breast cancer cell lines MDA-MB-231 and BT-20 were purchased from China Center for Type Culture Collection (CCTCC).

[0025] 1.2 Drugs and reagents

[0026]

[0027]

[0028] 2. Experimental method:

[0029] 2.1 Cell culture

[0030] Human highly metastatic breast cancer cell line MDA-MB-231 was incubated with 1640 culture medium containing 10% FBS, 100 μg / ml penicillin, and 100 μg / ml streptomycin at 37°C, CO 2 Cultured in a cell incubator with a volume fraction of 5%.

[0031] 2.2 "Scratch healing" method to detect the effect of different concentrations of drugs on the migration ability of MDA-MB-231 cells

[0032] Take MDA-MB-231 and BT-20 c...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses application of 3,5-di-tert-butyl copper salicylate to preparing drug for treating high-metastatic breast cancer and administration dosage of 3,5-di-tert-butyl copper salicylate. Experiments prove that 3,5-di-tert-butyl copper salicylate can inhibit transfer of breast cancer cells, and breast cancer cell invasion is inhibited through concentration dependence. New medical application of 3,5-di-tert-butyl copper salicylate is developed, and a new application field is exploited.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to the application of copper 3,5-di-tert-butyl salicylate in the preparation of medicines for treating highly metastatic breast cancer. Background technique [0002] Breast cancer is by far the most common cancer among women worldwide. About 500,000 people die from breast cancer every year in the world, which poses a serious threat to women's life and quality of life. Breast cancer has also become the most common cancer among Chinese women; the annual number of new breast cancer cases and deaths in China account for 12.2% and 9.6% of the world's total respectively. With the acceleration of the pace of life and the aggravation of work pressure, breast cancer patients are showing a trend of younger age and higher incidence. At present, the treatment of breast cancer mainly adopts surgical resection and chemotherapy, but for highly metastatic breast cancer, none of the existing trea...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/60A61P35/00
CPCA61K31/60
Inventor 徐金华柳昀熠范丽梅童玉华
Owner JIANGHAN UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com